SynthesisFrontiers in oncology2026

Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials.

Artem Oganesyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.